Toripalimab in Combination With Nab-Paclitaxel For Patients With Metastatic or Recurrent Triple-Negative Breast Cancer (TNBC) With or Without Systemic Treatment

NCT04085276 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

531

Enrollment

OTHER

Sponsor class

Conditions

Triple-Negative Breast Cancer

Interventions

DRUG: JS001
DRUG: Nab-Paclitaxel
DRUG: Placebo
DRUG: Nab-Paclitaxel

Sponsor

Shanghai Junshi Bioscience Co., Ltd.